PCRI Executive Director, Mark Scholz, MD, explains how monitor and stage prostate cancer.

Low testosterone (“Low T”), or hypogonadism, is typically encountered by men when they arrive at middle or late stages of life. The symptoms are increased…

Dendreon Pharmaceuticals LLC announced it will conduct a large-scale, placebo-controlled clinical trial evaluating the effectiveness of PROVENGE® (sipuleucel-T) in reducing disease progression in men with prostate cancer on active surveillance (AS).

Perhaps forty years ago the abdominal crunch (AC) was originally promoted as being a “safer” alternative to the classical sit up exercise. It’s still a popular “core training” exercise today, but I haven’t used it for my clients in many years and I also can’t remember the last time I’ve seen the fitness trainers I rub shoulders with use it either.

The Prostate Cancer Research Institute is delighted to announce Prostate Digest, the new format for what was formerly Prostate Insights Magazine. Prostate Digest still contains articles from the most prestigious doctors in the field, clinical researchers, support group leaders, and PCRI’s staff. However, Prostate Digest comes in a newspaper! As before, we offer all articles online. If you prefer, you can receive articles directly to your email. Enter your email here or call us at 310-743-2116. To learn more about PCRI, our Medical Review Board, and our Board of Directors, click here. 

Surgery and radiation are the most commonly administered prostate cancer treatments. There are many factors to consider before making a treatment choice. Every man’s prostate cancer case is different, so the same treatment(s) can lead to different outcomes, especially when it comes to side effects. Often, men undergo surgery or radiation (or both) without being...

Prostatitis is associated with inflammation (and or neural upregulation or sensitization), and in a few cases, infection of the prostate, causing pain in the prostate and pelvic area along with variable urinary symptoms. Acute bacterial prostatitis is rare, quite severe, relatively simple to diagnose, and quite easy to cure with...

Before discussing recovery of erectile function in men following radical prostatectomy, it is important to understand the current causes and treatments for ED. There are many causes of ED. ED is a progressive disease in which 40% of men at 40 years old, 60% of men at 60 years old, and 80% of men at 80 years old will develop ED. [1] The most common causes are associated with diabetes and prostate cancer. Diabetics are four times more...

This month I re-read Younger Next Year, a book by Harry S. Lodge, M.D., and Chris Crowley. I chose this month to post on it to honor the one-year anniversary of Dr. Lodge’s death from prostate cancer in March 2017. First published in 2004, the book has sold millions of...

At the first ever Active Surveillance Convention, a conference I attended back in 2007, many experts openly bemoaned that the word “CANCER” profoundly overstates the significance of Gleason 6 type of prostate cancer. The pathologists at the conference, however, shot down the idea of a name change saying, “Under the microscope it looks like a cancer, so it is cancer.” No one at the conference had    a rebuttal so the proposal for a name change was dropped.